Resveratrol derivatives as a pharmacological tool (Q39413479)

11 September 2017

1 reference

title

Resveratrol derivatives as a pharmacological tool (English)

1 reference

11 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Michele Azzolini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Matteo Romio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Lucia Biasutto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Martina La Spina

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Nicola Sassi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Cristina Paradisi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Mario Zoratti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

4 July 2017

1 reference

Annals of the New York Academy of Sciences

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

1403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

27-37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

Polyphenols and the human brain: plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefits

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Biosynthesis, metabolism, molecular engineering, and biological functions of stilbene phytoalexins in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

A stress-inducible resveratrol O-methyltransferase involved in the biosynthesis of pterostilbene in grapevine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Bioavailability of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Metabolism and bioavailability of trans-resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Challenges in Analyzing the Biological Effects of Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol commonly displays hormesis: occurrence and biomedical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol and cancer treatment: is hormesis a yet unsolved matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Targeting cancer stem-like cells using dietary-derived agents - Where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol in cancer management: where are we and where we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol and health: the starting point

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Inhibition of cancer growth by resveratrol is related to its low bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Challenges of translating basic research into therapeutics: resveratrol as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

The Use of Stilbene Scaffold in Medicinal Chemistry and Multi- Target Drug Design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol analogs: promising chemopreventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Chemopreventive effects of resveratrol and resveratrol derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Prodrugs: design and clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Cytotoxic, Antiangiogenic and Antitelomerase Activity of Glucosyl- and Acyl- Resveratrol Prodrugs and Resveratrol Sulfate Metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Absorption and metabolism of resveratrol carboxyesters and methanesulfonate by explanted rat intestinal segments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4'-tri-O-acetylresveratrol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Soluble polyphenols: synthesis and bioavailability of 3,4',5-tri(alpha-D-glucose-3-O-succinyl) resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Prodrugs of quercetin and resveratrol: a strategy under development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Amino acid-PEGylated resveratrol and its influence on solubility and the controlled release behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Novel Resveratrol-Based Aspirin Prodrugs: Synthesis, Metabolism, and Anticancer Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Preventive oral treatment with resveratrol pro-prodrugs drastically reduce colon inflammation in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Qualitative structure-metabolism relationships in the hydrolysis of carbamates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Irinotecan (CPT-11): recent developments and future directions--colorectal cancer and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Synthesis and Evaluation as Prodrugs of Hydrophilic Carbamate Ester Analogues of Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Amino Acid Carbamates As Prodrugs Of Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Mitochondrial pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Mitochondrially targeted anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Mitochondrial effects of plant-made compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Targeting lipophilic cations to mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Development of mitochondria-targeted derivatives of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Mitochondria-targeted resveratrol derivatives act as cytotoxic pro-oxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Synthesis and testing of novel isomeric mitochondriotropic derivatives of resveratrol and quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Cytotoxicity of mitochondria-targeted resveratrol derivatives: interactions with respiratory chain complexes and ATP synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Pharmacokinetics and tissue distribution of pterostilbene in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Small-molecule targeting of the mitochondrial compartment with an endogenously cleaved reversible tag.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Animal and human studies with the mitochondria-targeted antioxidant MitoQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Acetal Derivatives as Prodrugs of Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

New Water-Soluble Carbamate Ester Derivatives of Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

N-Monosubstituted Methoxy-oligo(ethylene glycol) Carbamate Ester Prodrugs of Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

Cytotoxicity of a mitochondriotropic quercetin derivative: Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13401

21 January 2018

Identifiers

DOI

10.1111/NYAS.13401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28675763%20AND%20SRC:MED&resulttype=core&format=json

release_ivdhidpt3jespoodldwkvzb4vq

3 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ivdhidpt3jespoodldwkvzb4vq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference